Predictive Value of Patient-Derived Tumor Cell Cluster–Based Drug Sensitivity Assay in Advanced NSCLC
Authors
- Zhentao Liu (ORCID: https://orcid.org/0000-0001-5188-3235)
- Shenyi Yin (ORCID: https://orcid.org/0000-0003-2731-5689)
- Yangchun Gu (ORCID: https://orcid.org/0000-0003-3278-7285)
- Juan Li (ORCID: https://orcid.org/0000-0001-8320-2406)
- Lu Yang (ORCID: https://orcid.org/0000-0002-4286-9586)
- Leilei Yang (ORCID: https://orcid.org/0000-0002-4737-7652)
- Hua Zhang (ORCID: https://orcid.org/0000-0002-9103-4796)
- Baoshan Cao (ORCID: https://orcid.org/0000-0001-7939-4820)
- H. Huang (ORCID: https://orcid.org/0009-0005-2859-4319)
- Jinyu Yu (ORCID: https://orcid.org/0009-0003-7584-0354)
Institutions
- Peking University (CN)
- Annoroad Gene Technology (China) (CN)
- Peking University Third Hospital (CN)
Publication Details
- Journal
- Clinical Medicine Insights Oncology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1177/11795549251405740
- Primary Topic
- Radiomics and Machine Learning in Medical Imaging
- Type
- article
- Field-Weighted Citation Impact
- 0.00